Single Article Purchase:
Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes MellitusAleglitazar and Cardiovascular Outcomes After ACS in T2D PatientsAleglitazar and Cardiovascular Outcomes After ACS in T2D Patients
Lincoff A, Tardif J, Schwartz GG, et al.
Published online April 16, 2014
Choose criteria for pricing info
Want online access for an institution? Learn More/Request Quote >
Obtain AMA PRA Category 1 Credit™ by reading an article and completing an online quiz. Quizzes are available to AMA Members, subscribers, and those who have purchased tokens.